A Double-Blind, Placebo-Controlled Study of Atomoxetine in Young Children With ADHD

OBJECTIVE: To evaluate the efficacy and tolerability of atomoxetine for the treatment of attention-deficit/hyperactivity disorder (ADHD) in 5- and 6-year-old children. METHODS: This was an 8-week, double-blind, placebo-controlled randomized clinical trial of atomoxetine in 101 children with ADHD. At...

Full description

Saved in:
Bibliographic Details
Main Authors: Kratochvil, Christopher J., Vaughan, Brigette S., Stoner, Julie A., Daughton, Joan M., Lubberstedt, Brian D., Murray, Desiree W., Chrisman, Allan K., Faircloth, Melissa A., Itchon-Ramos, Nilda B., Kollins, Scott H., Maayan, Lawrence A., Greenhill, Laurence L., Kotler, Lisa A., Fried, Jane, March, John S.
Format: Artigo
Language:Inglês
Published: American Academy of Pediatrics 2011
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3387889/
https://ncbi.nlm.nih.gov/pubmed/21422081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2010-0825
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items